Study S000959

Conduct of the REsponses in Function and Outcomes From RYGB vs. Medication Study (REFORM) Study by Research Coordinators

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT07115069
Acronym: REFORM
Study type: OBSERVATIONAL
Status: ACTIVE_NOT_RECRUITING
Enrollment: 60
Start: 2025-08-09
Primary completion: 2027-06
Lead sponsor: Vanderbilt University Medical Center
Conditions: Obesity
Interventions: DRUG:GLP-1 receptor agonist; PROCEDURE:Gastric Bypass Surgery (laparoscopic); PROCEDURE:Gastric Bypass Surgery (robotic)
Results posted: FALSE
Individual participant data sharing: YES
Secondary identifiers: OTHER:U16066

Registered primary outcomes

Skeletal Muscle Loss [6 months]
Skeletal Muscle Loss [12 months]
Patient Assessment of Upper Gastrointestinal Disorders Symptoms Questionnaire [6 months]
Patient Assessment of Upper Gastrointestinal Disorders Symptoms Questionnaire [12 months]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.